Digoxin Levels and the Two Ranges Still in Circulation

Two therapeutic ranges for digoxin are in circulation right now, and study material prints both without saying which is which. One is current and traceable to a source you can open. The other is an older convention that never quite left. Knowing they differ beats picking a side.

The range we can actually source

StatPearls gives a therapeutic digoxin range of 0.8 to 2.0 ng/mL, with toxicity described above 2.4 ng/mL. That is the figure we teach, because it comes from a document we fetched and read rather than from a chart that copied another chart.

Note the gap between those two numbers. A level of 2.2 ng/mL sits above the therapeutic band and below the figure the source attaches to toxicity, and a patient sitting there is neither automatically in crisis nor automatically fine.

That grey zone is where assessment does the work. The level is one input. The patient is the other.

The older convention, and why it is still everywhere

You will also find a therapeutic range of 0.5 to 2.0 ng/mL, with a lower floor. We could not verify it to the same standard, so we label it for what it is: an older convention that is still widely reprinted.

If your instructor teaches the lower floor, they are not being careless. Reference ranges shift as evidence accumulates, and a value called therapeutic under one convention can be called low under another. What nobody should do is quote one band and present it as settled.

Ranges also vary slightly between laboratories, which MedlinePlus states in its own reference material. The band printed on your patient's report outranks anything in your notes.

Saying the disagreement out loud

Naming both ranges reads as weakness on a flashcard and as strength in a clinical conversation. It is the second one that matters here.

There is a practical payoff too. If an exam item and a clinical instructor use different floors, you will recognise a source disagreement instead of assuming you learned it wrong. That recognition is worth more than either number by itself.

It is the same habit how to study lab values without memorizing a wall argues for across every panel. Carry the caveat with the value, not in a separate paragraph you forget under pressure.

Why the level alone is not the answer

A digoxin level is a snapshot of the drug, not of the patient. Two people can sit at the same level and be in very different trouble, because renal function, age and electrolytes all change what that level does.

Potassium is the loudest of those variables and it works in both directions. That interaction has its own post, potassium and digoxin, a two way danger, because a paragraph here would flatten it.

The clinical picture of toxicity, from the earliest gastrointestinal complaints through the visual changes to the rhythm findings, is handled separately in digoxin toxicity, from nausea to bidirectional VT. What belongs here is the number.

Reading the level next to the kidney

Digoxin is cleared renally, so a rising creatinine is a warning about the level before the level is even drawn. MedlinePlus publishes a serum creatinine reference range of 0.8 to 1.2 mg/dL and a blood urea nitrogen range of 6 to 20 mg/dL, and those two rows deserve a look on the same page as the drug level.

Age belongs in the same thought. Renal clearance declines across a lifetime, so an older patient on a stable dose can drift upward without anything visibly changing in the prescription.

That is why a digoxin item so often includes a creatinine you were not expecting to need. The stem is not padding. It is handing you the mechanism.

Before the dose, not after

Most facilities attach a heart rate parameter to digoxin, with an order naming the rate below which the dose is held and the prescriber is notified. Follow the parameter written for your patient rather than one you memorised, because that order is what your documentation will be measured against.

Assess before you give. Count an apical pulse for a full minute, note the rhythm, and ask about the symptoms that would make you suspicious of accumulation.

Working a level inside a stem

Work in this order. Find the level. Name the band you are grading it against and say which convention that band comes from. Then look at what else the stem has handed you.

Timing matters more than students expect. A level drawn too soon after a dose reads high for reasons that have nothing to do with accumulation, so a stem that tells you when the dose was given is telling you for a reason.

If several results are abnormal at once, ranking them is its own skill. Which lab result do you report first works through how to order them when everything on the page looks wrong.

A worked reading

A patient on long term digoxin has a level of 2.6 ng/mL and has been nauseated since yesterday. Against the sourced band, that level is above therapeutic and above the figure the source attaches to toxicity, and the symptom is consistent with it.

Change the level to 1.6 ng/mL with the same nausea and the reading changes shape. That level sits inside the sourced therapeutic band, so the nausea needs another explanation, and the next step is more assessment rather than a conclusion.

Both readings needed the band named out loud first. Under the older convention the second level looks even more comfortably mid range, which is the practical reason we bother saying which convention we are using.

The habit this builds

Digoxin is the clearest example of a value with a contested floor, and it is not the only one. Lithium carries two therapeutic bands for two phases of treatment, and its source changes units partway through the toxicity staging. Lithium levels for acute mania versus maintenance walks through that.

Get comfortable holding two numbers at once. It is not indecision. It is what the literature actually looks like, and pretending otherwise is how a study source ends up teaching you something it cannot support.